BSc, MD, FRCPC, FAAP
Preferred method of communication
Research and teaching
- Bone marrow transplantation for sickle cell disease
- acute and late effects of cancer therapy
Summary of Research
Research interests include acute and late toxicities of BMT, as well as the study of novel low-toxicity approaches to transplant for pediatric non-malignant diseases. Greg is interested in studying graft survival post BMT, novel methods of evaluation chimerisms, family BMT decision-making, and neuropsychological outcomes. He also has an interest in pediatric BMT donor safety. A career goal is to expand access to BMT for sickle cell disease to low and middle income countries.Greg is a site investigator for numerous phase I, II and III clinical trials.
Co-Lead of the Alberta Children’s Hospital Hematopoietic Cell Transplant Long-Term Survivor Program, Chair Mentee of the Children’s Oncology Group HCT/Dermatology/Immunology Late Effects Taskforce, Vice Chair of the Board of Directors of the Sickle Transplant Alliance for Research, Vice-Chair of the Royal College Pediatric Hematology/Oncology Examination Committee, Program Director for Pediatric Hematology/Oncology at the University of Calgary.